Global Clinical Decision Support Systems (CDSS) Market by Model, Mode of Delivery, Component, Product, Application, and Geography - Forecast to 2023
DUBLIN, Aug. 20, 2018 /PRNewswire/ --
The "Global Clinical Decision Support Systems Market - Segmented by Model, Mode of Delivery, Component, Product, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The clinical decision support systems market is expected to grow at a CAGR of about 11% during the forecast period.
Need for Reducing Human Errors
Determining accurate medication doses is a difficult and time-consuming process and especially critical for infants and children in emergency situations. Calculations involving intricate formulas are often difficult to memorize, and mathematical errors can still occur even when the formulas are accurately recalled. Varying dosing programs based on indication and pharmacokinetics represent additional opportunities for error.
Clinical decision support systems can give physicians and nurses easy and quick access to drug-specific dosing calculators, full drug profiles with age, weight, disease and renal adjustment dosing, and much more. Accurate medication information and dosing calculators, easily accessible within the medical workflow, can provide a significant reduction in errors. Owing to these capabilities of the system, there will be a boost in the growth of the clinical decision support systems market.
Other factors that will affect the growth of this market include rising demand to reduce healthcare expenditure, need for improvement in quality of care, rising chronic disease population, and more adoption rate in emerging economies.
Lack of Trust in the System as CDSS is in its Initial Stages of Development
The most often recurring barriers to CDSS implementation included earlier experience of dysfunctional computer systems in health care, general resistance towards changes in practice, and time management issues. In a study conducted by Oxford University, all groups listed numerous examples of dysfunctional healthcare IT systems, and they were worried of consequences if CDSS is built on the existing imperfect systems.
This lack of trust in the healthcare professionals will lead to them not including for CDSS in their practice. This will eventually lead to the slowdown of the growth of this market. Other factors that will influence the decline of this market include lack of skilled labor, and suggestions from CDSS for unnecessary diagnostic testing will hinder the market growth.
North America to Maintain Dominance
North America is the leading market in the world, followed by Europe. Asia-Pacific is the fastest developing region. The large market share of North America can be attributed to factors such as the rising demand for quality healthcare delivery, need to curb increasing healthcare expenditure, and implementation of favorable initiatives & regulations are driving the growth of the CDSS market in the United States.
Developments in the Market
- February 2018 - The US Food and Drug Administration (FDA) announced marketing clearance for Viz.AI's Contact application, the first artificial intelligence-based clinical decision support (CDS) solution cleared for sale in the United States. Viz.AI Contact is designed to analyze computed tomography (CT) results.
Key Topics Covered
1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Need for Reducing Human Errors
6.1.2 Rising Demand to Reduce Healthcare Expenditure
6.1.3 Need for Improvement in Quality of Care
6.1.4 Rising Chronic Disease Population
6.1.5 Showing More Adoption in Emerging Economies
6.2 Market Restraints
6.2.1 Lack of Skilled Professional
6.2.2 Suggestions from CDSS for Unnecessary Diagnostic Testing
6.2.3 Lack of Trust in the System due to CDSS being in its Initial Stages of Developement
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Model
7.1.1 Knowledge-based CDSS
7.1.2 Non-Knowledge CDSS
7.1.3 Others
7.2 By Mode of Delivery
7.2.1 Web-based
7.2.2 Cloud-based
7.2.3 On-premise
7.3 By Component
7.3.1 Hardware
7.3.2 Software
7.3.3 Services
7.4 By Product
7.4.1 Integrated Systems
7.4.2 Standalone Systems
7.4.3 Standard-based
7.4.4 Service model-based
7.4.5 Others
7.5 By Application
7.5.1 Medical Diagnosis
7.5.2 Alerts & Reminders
7.5.3 Prescription Decision Support
7.5.4 Information Retrieval
7.5.5 Image Recognition and Interpretation
7.5.6 Therapy Critiquing & Planning
7.5.7 Others
7.6 By Geography
7.6.1 North America
7.6.1.1 United States
7.6.1.2 Canada
7.6.1.3 Mexico
7.6.2 Europe
7.6.2.1 France
7.6.2.2 Germany
7.6.2.3 United kingdom
7.6.2.4 Italy
7.6.2.5 Spain
7.6.2.6 Rest of Europe
7.6.3 Asia-Pacific
7.6.3.1 India
7.6.3.2 Australia & New Zealand
7.6.3.3 South Korea
7.6.3.4 Rest of Asia-Pacific
7.6.4 Rest of the World
7.6.4.1 Saudi Arabia
7.6.4.2 Brazil
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Cerner Corporation
9.2 EPIC
9.3 IBM
9.4 Mckesson Corporation
9.5 Meditech
9.6 Phillips Healthcare
9.7 Siemens Healthcare
List Not Exhaustive
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/jtft7m/global_clinical?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article